Editorial: Exploring genomic instability of cancers: applications in diagnosis and treatment.
作者信息
Zhang Dong, Lin Shiaw-Yih, Lee Marietta
机构信息
Department of Biomedical Sciences, College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, NY, United States.
Center for Cancer Research, New York Institute of Technology, Old Westbury, NY, United States.
出版信息
Front Cell Dev Biol. 2025 Feb 7;13:1528281. doi: 10.3389/fcell.2025.1528281. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Exploring genomic instability of cancers: applications in diagnosis and treatment.社论：探索癌症的基因组不稳定性：在诊断和治疗中的应用
Front Cell Dev Biol. 2025 Feb 7;13:1528281. doi: 10.3389/fcell.2025.1528281. eCollection 2025.
2
A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.前列腺癌“弥漫性”：基因组不稳定性和 SChLAP1 失调是导管内和筛状亚型恶性进展的基础。
Eur Urol. 2017 Nov;72(5):665-674. doi: 10.1016/j.eururo.2017.04.034. Epub 2017 May 13.
3
Characterization of genomic instability-related genes predicts survival and therapeutic response in lung adenocarcinoma.基因组不稳定性相关基因的特征可预测肺腺癌的生存和治疗反应。
BMC Cancer. 2023 Nov 16;23(1):1115. doi: 10.1186/s12885-023-11580-0.
4
A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma.一种新型基于基因组不稳定性的 lncRNA 标志物，用于预测胰腺导管腺癌的预后和免疫特征。
Front Immunol. 2022 Sep 15;13:970588. doi: 10.3389/fimmu.2022.970588. eCollection 2022.
5
Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.胰腺腺癌中的基因组不稳定：迈向精准医学和新型治疗方法的新进展。
Expert Rev Gastroenterol Hepatol. 2016 Aug;10(8):893-905. doi: 10.1586/17474124.2016.1153424. Epub 2016 Feb 26.
6
Computational detection of a genome instability-derived lncRNA signature for predicting the clinical outcome of lung adenocarcinoma.基于基因组不稳定性特征的 lncRNA signature 用于预测肺腺癌临床预后的计算检测。
Cancer Med. 2022 Feb;11(3):864-879. doi: 10.1002/cam4.4471. Epub 2021 Dec 5.
7
Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma.APE1 上调失调导致同源重组和细胞周期失控，推动食管腺癌的基因组进化、肿瘤发生和化疗耐药。
Gastroenterology. 2023 Aug;165(2):357-373. doi: 10.1053/j.gastro.2023.04.035. Epub 2023 May 12.
8
From Therapy to Cancer Prevention Using HRD Testing on Patients with High-grade Ovarian Cancer.从治疗到癌症预防：对高级别卵巢癌患者进行HRD检测的应用
Cancer Prev Res (Phila). 2025 Jul 1;18(7):393-400. doi: 10.1158/1940-6207.CAPR-24-0474.
9
Tumor Hypoxia Drives Genomic Instability.肿瘤缺氧导致基因组不稳定。
Front Cell Dev Biol. 2021 Mar 16;9:626229. doi: 10.3389/fcell.2021.626229. eCollection 2021.
10
Genomic instability in patients with non-small cell lung cancer assessed by the arbitrarily primed polymerase chain reaction.通过任意引物聚合酶链反应评估非小细胞肺癌患者的基因组不稳定性。
Cancer Invest. 2008 Apr-May;26(3):262-8. doi: 10.1080/07357900701708385.
本文引用的文献
1
Targeting DNA damage response pathways in cancer.靶向癌症中的DNA损伤反应通路。
Nat Rev Cancer. 2023 Feb;23(2):78-94. doi: 10.1038/s41568-022-00535-5. Epub 2022 Dec 5.
2
Targeting the DNA damage response in immuno-oncology: developments and opportunities.靶向免疫肿瘤学中的 DNA 损伤反应：进展与机遇。
Nat Rev Cancer. 2021 Nov;21(11):701-717. doi: 10.1038/s41568-021-00386-6. Epub 2021 Aug 10.
3
Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies.肿瘤缺氧调控免疫逃逸/浸润：对血管生成的影响及缺氧生物标志物对癌症治疗的潜在影响。
Front Immunol. 2021 Jan 20;11:613114. doi: 10.3389/fimmu.2020.613114. eCollection 2020.
4
A guide to cancer immunotherapy: from T cell basic science to clinical practice.癌症免疫疗法指南：从 T 细胞基础科学到临床实践。
Nat Rev Immunol. 2020 Nov;20(11):651-668. doi: 10.1038/s41577-020-0306-5. Epub 2020 May 20.
5
FANCM suppresses DNA replication stress at ALT telomeres by disrupting TERRA R-loops.FANCM 通过破坏 TERRA R-环来抑制 ALT 端粒处的 DNA 复制应激。
Sci Rep. 2019 Dec 13;9(1):19110. doi: 10.1038/s41598-019-55537-5.
6
The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT).FANCM-BLM-TOP3A-RMI 复合物抑制端粒的 ALT 延长。
Nat Commun. 2019 May 28;10(1):2252. doi: 10.1038/s41467-019-10180-6.
7
FANCM limits ALT activity by restricting telomeric replication stress induced by deregulated BLM and R-loops.FANCM 通过限制 BLM 和 R 环引起的端粒复制应激来限制 ALT 活性。
Nat Commun. 2019 May 28;10(1):2253. doi: 10.1038/s41467-019-10179-z.
8
State-of-the-art strategies for targeting the DNA damage response in cancer.针对癌症中 DNA 损伤反应的最新策略。
Nat Rev Clin Oncol. 2019 Feb;16(2):81-104. doi: 10.1038/s41571-018-0114-z.
9
FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres.FANCM、BRCA1 和 BLM 协同作用解决 ALT 端粒的复制应激。
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5940-E5949. doi: 10.1073/pnas.1708065114. Epub 2017 Jul 3.
10
Two decades after BRCA: setting paradigms in personalized cancer care and prevention.BRCA 研究二十年：开创个体化癌症治疗与预防的新纪元。
Science. 2014 Mar 28;343(6178):1466-70. doi: 10.1126/science.1251827.
Zotero 插件